Evidence map›Paper›PMID 26640614›Full record

ReviewOxidative medicine and cellular longevity2016

Redox Modulations, Antioxidants, and Neuropsychiatric Disorders.

Erik A Fraunberger, Gustavo Scola, Victoria L M Laliberté, Angela Duong, Ana C Andreazza

Abstract readReview
In one paragraph

Review in Oxidative medicine and cellular longevity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Catalytic antioxidant nanoparticles mitigate secondary injury progression and promote functional recovery in spinal cord injury model.Journal of controlled release : official journal of the Controlled Release Society · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Our (Mother's) Mitochondria and Our Mind.Perspectives on psychological science : a journal of the Association for Psychological Science · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Erik A FraunbergerCentre for Addiction and Mental Health, 250 College Street, Toronto, ON, Canada M5T 1R8 ; Department of Pharmacology, University of Toronto, Medical Science Building, 1 King's College Circle, Toronto, ON, Canada M5S 1A8.
Gustavo ScolaCentre for Addiction and Mental Health, 250 College Street, Toronto, ON, Canada M5T 1R8 ; Department of Psychiatry, University of Toronto, 250 College Street, Toronto, ON, Canada M5T 1R8.
Victoria L M LalibertéDepartment of Pharmacology, University of Toronto, Medical Science Building, 1 King's College Circle, Toronto, ON, Canada M5S 1A8.
Angela DuongDepartment of Pharmacology, University of Toronto, Medical Science Building, 1 King's College Circle, Toronto, ON, Canada M5S 1A8.
Ana C AndreazzaCentre for Addiction and Mental Health, 250 College Street, Toronto, ON, Canada M5T 1R8 ; Department of Pharmacology, University of Toronto, Medical Science Building, 1 King's College Circle, Toronto, ON, Canada M5S 1A8 ; Department of Psychiatry, University of Toronto, 250 College Street, Toronto, ON, Canada M5T 1R8.

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

Although antioxidants, redox modulations, and neuropsychiatric disorders have been widely studied for many years, the field would benefit from an integrative and corroborative review. Our primary objective is to delineate the biological significance of compounds that modulate our redox status (i.e., reactive species and antioxidants) as well as outline their current role in brain health and the impact of redox modulations on the severity of illnesses. Therefore, this review will not enter into the debate regarding the perceived medical legitimacy of antioxidants but rather seek to clarify their abilities and limitations. With this in mind, antioxidants may be interpreted as natural products with significant pharmacological actions in the body. A renewed understanding of these often overlooked compounds will allow us to critically appraise the current literature and provide an informed, novel perspective on an important healthcare issue. In this review, we will introduce the complex topics of redox modulations and their role in the development of select neuropsychiatric disorders.

Indexed as

Mental DisordersNervous System DiseasesAntioxidantsBrainHumansAntioxidants

Identifiers

PMID26640614
PMCPMC4657108

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.